Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
---|---|---|---|---|---|
03.01. | Tivic Health Systems, Inc. - 8-K, Current Report | - | SEC Filings | ||
23.12.24 | Tivic Health Systems, Inc. - 8-K, Current Report | 1 | SEC Filings | ||
13.12.24 | Tivic Health-Aktie stürzt auf 52-Wochen-Tief von 0,22 US-Dollar | 1 | Investing.com Deutsch | ||
TIVIC HEALTH SYSTEMS Aktie jetzt für 0€ handeln | |||||
13.12.24 | Tivic Health stock plunges to 52-week low of $0.22 | 1 | Investing.com | ||
15.11.24 | Tivic Health Systems GAAP EPS of -$0.23, revenue of $126K | 8 | Seeking Alpha | ||
15.11.24 | Tivic Reports Third Quarter 2024 Financial Results and Provides Business Update | 127 | Business Wire | FREMONT, Calif.--(BUSINESS WIRE)--Tivic Health® Systems, Inc. (Nasdaq: TIVC), a health tech company that develops and commercializes bioelectronic medicine, today announced third quarter and nine-months... ► Artikel lesen | |
14.11.24 | Tivic completes enrollment in nerve stim trial | 1 | MassDevice | ||
12.11.24 | Tivic Health Systems, Inc.: Tivic Health Validates European Patents in Great Britain, Germany, and France | 230 | Business Wire | Patents cover methods used to identify key treatment points and dynamically personalize simulation
Tivic Health® Systems, Inc. (Nasdaq: TIVC), a health tech company developing and commercializing... ► Artikel lesen | |
18.09.24 | Tivic Health macht Fortschritte bei nicht-invasiver Nervenstimulation | 13 | Investing.com Deutsch | ||
18.09.24 | Tivic Health advances in non-invasive nerve stimulation | 1 | Investing.com | ||
17.09.24 | Tivic Health partners with Fletcher Spaght for growth strategy | 1 | Investing.com | ||
13.09.24 | Tivic Health names Lisa Wolf as interim CFO | 1 | Seeking Alpha | ||
13.09.24 | Tivic Health Systems, Inc. - 8-K, Current Report | 2 | SEC Filings | ||
14.08.24 | Tivic Health Systems GAAP EPS of -$0.32, revenue of $0.14M | 1 | Seeking Alpha | ||
14.08.24 | Tivic Reports Second Quarter 2024 Financial Results | 189 | Business Wire | SAN FRANCISCO--(BUSINESS WIRE)--Tivic Health® Systems, Inc. ("Tivic", Nasdaq: TIVC), a health tech company that develops and commercializes bioelectronic medicine, today announced its second quarter... ► Artikel lesen | |
02.08.24 | Tivic Health Systems, Inc. - 8-K, Current Report | 1 | SEC Filings | ||
29.07.24 | Tivic Health Systems (TIVC) Stock Pops Another 39% | 4 | InvestorPlace | ||
23.07.24 | Tivic Health Systems, Inc.: Tivic Health Expands Intellectual Property Portfolio | 316 | Business Wire | Three New Patents Granted in the US and Europe Tivic Health® Systems, Inc. ("Tivic Health", Nasdaq: TIVC), a health tech company that develops and commercializes bioelectronic medicine, announced... ► Artikel lesen | |
15.05.24 | Tivic Reports First Quarter 2024 Financial Results and Subsequent Events | 139 | Business Wire | SAN FRANCISCO--(BUSINESS WIRE)--Tivic Health® Systems, Inc. ("Tivic", Nasdaq: TIVC), a health tech company that develops and commercializes bioelectronic medicine, today announced its first quarter... ► Artikel lesen | |
25.03.24 | Tivic Reports Fiscal Year 2023 Financial Results | 556 | Business Wire | SAN FRANCISCO--(BUSINESS WIRE)--Tivic Health® Systems, Inc. ("Tivic", Nasdaq: TIVC), a health tech company that develops and commercializes bioelectronic medicine, today announced its financial... ► Artikel lesen |
Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
---|---|---|---|---|---|
FRESENIUS | 36,720 | -0,22 % | Leichte Zugewinne bei der Fresenius SE & Co. KGaA-Aktie (36,58 €) | Das Wertpapier von Fresenius SE & Co. KGaA notiert heute fester. Der jüngste Kurs betrug 36,58 Euro. Die Fresenius+Co KgaA-Aktie verzeichnet gegenwärtig einen Wertanstieg von 2,75 Prozent. Sie hat sich... ► Artikel lesen | |
SIEMENS HEALTHINEERS | 53,48 | -1,58 % | UBS stuft Siemens Healthineers auf 'Neutral' | ZÜRICH (dpa-AFX Analyser) - Die Schweizer Großbank UBS hat die Einstufung für Siemens Healthineers mit einem Kursziel von 53 Euro auf "Neutral" belassen. Im europäischen Medizintechnik-Bereich gebe... ► Artikel lesen | |
CARL ZEISS MEDITEC | 56,30 | +6,03 % | JPMORGAN stuft CARL ZEISS MEDITEC AG auf 'Underweight' | NEW YORK (dpa-AFX Analyser) - Die US-Bank JPMorgan hat die Einstufung für Carl Zeiss Meditec mit einem Kursziel von 40 Euro auf "Underweight" belassen. Das erste Geschäftsquartal dürfte mau ausfallen... ► Artikel lesen | |
GERRESHEIMER | 64,85 | +1,25 % | EQS-PVR: Gerresheimer AG: Release according to Article 40, Section 1 of the WpHG [the German Securities Trading Act] with the objective of Europe-wide distribution | EQS Voting Rights Announcement: Gerresheimer AG
Gerresheimer AG: Release according to Article 40, Section 1 of the WpHG [the German Securities Trading Act] with the objective of... ► Artikel lesen | |
FRESENIUS MEDICAL CARE | 46,650 | +0,09 % | GOLDMAN SACHS stuft FMC FRESENIUS MEDICAL CARE AG & CO KGAA auf 'Buy' | NEW YORK (dpa-AFX Analyser) - Die US-Investmentbank Goldman Sachs hat die Einstufung für FMC mit einem Kursziel von 52 Euro auf "Buy" belassen. Analyst Richard Felton nahm in einer am Montagabend vorliegenden... ► Artikel lesen | |
ECKERT & ZIEGLER | 53,30 | +5,96 % | AKTIONÄR-Tipp Telix Pharma: Zulassung - darum profitiert auch Eckert & Ziegler | In den USA wird das radiopharmazeutische Diagnostik-Produkt Illuccix bereits regelrecht aus den Regalen gerissen. Entwickler Telix Pharma kann den Top-Seller nun auch in Europa auf den Markt bringen.... ► Artikel lesen | |
INTUITIVE SURGICAL | 554,90 | -4,93 % | Soll ich diese Aktien jetzt kaufen? Intel, Intuitive Surgical und UnitedHealth im Check | Soll ich diese Aktien jetzt kaufen? Intel, Intuitive Surgical und UnitedHealth im Chec ► Artikel lesen | |
ALLURION TECHNOLOGIES | 8,230 | +159,62 % | Pre-market Movers: Allurion Technologies, Nvni Group, Dogwood Therapeutics, Jupiter Neurosciences, Ctrl Group | BRASILIA (dpa-AFX) - The following are some of the stocks making big moves in Friday's pre-market trading (as of 08.15 A.M. ET).In the Green Allurion Technologies Inc. (ALUR) is up over 297%... ► Artikel lesen | |
GENEDX | 79,02 | +1,75 % | GeneDx Announces Preliminary 2024 Financial Results | STAMFORD, Conn.--(BUSINESS WIRE)--GeneDx Holdings Corp. (Nasdaq: WGS), a leader in delivering improved health outcomes through genomic insights, today reported preliminary financial results for... ► Artikel lesen | |
PROCEPT BIOROBOTICS | 72,05 | +3,55 % | How Is The Market Feeling About PROCEPT BioRobotics? | ||
BIOTEST | 26,900 | +0,37 % | Aktien KW 2 - US-Jobmarkt verdirbt die Party? Woche mit Paukenschlag. News. Auto1. Mutares. Nvidia. Kion. Magirus. Fuchs. INDUS. Biotest. Circus | Aktien Wochenrückblick - nach zwei ruhigen feiertagsgeprägten Wochen sah es diese Woche wieder so aus, als ob der DAX wieder auf Rekordkurs gehen wollte. Angebrannt ist nichts, aber die US-Jobdaten... ► Artikel lesen | |
HIMS & HERS HEALTH | 29,580 | -0,27 % | Hims & Hers Health COO Melissa Baird verkauft Aktien im Wert von 1,99 Millionen US-Dollar | ||
THERMO FISHER | 548,60 | -0,56 % | Is Thermo Fisher Stock Worth Holding on to in Your Portfolio? | ||
NANO-X IMAGING | 8,490 | -2,86 % | Nano-X Imaging LTD.: Nanox.ARC Imaging System Receives FDA Clearance for General Use, Including Pulmonary Indication | Nanox.ARC receives additional FDA clearance to produce tomographic images for general use, including pulmonary, intra-abdominal and paranasal indications, in addition to its previously cleared indication... ► Artikel lesen | |
PROGYNY | 22,060 | +0,18 % | Witness A Substantial Acquisition As DEBRA MORRIS Acquires Progyny Stock Options Worth $37K |